Skip to main content

Table 6 Comparison of the co-morbidities present in the two groups

From: Incidence of Venous Thromboembolism in cancer patients treated with Cisplatin based chemotherapy — a cohort study

Co-morbid Number in cisplatin group (%) Number in noncisplatin group (%)
N = 200 N = 200
Diabetes Mellitus 30 (15) 24 (12)
Hypertension 46 (23) 52 (26)
Coronary artery disease 10 (5) 08 (4)
Prior Atrial fibrillation 04 (2) 04 (2)
Prior history of TIA/Stroke 02 (1) 00
Renal Failure 00 00
Heart Failure 00 00